Ami Organics` manufacturing facility, Unit I situated at Sachin, Surat which is involved in manufacturing of various intermediates for Active Pharmaceuticals Ingredients, has undergone a Good Manufacturing Practices (GMP) inspection by Pharmaceutical and Medical Devices Agency, Japan (�PMDA�) starting 04 June 2024. The inspection has concluded successfully on 07 June 2024 without any critical/major observation.Powered by Capital Market - Live News

AMI Organics announced that the Board of Directors of the Company at its meeting held on 10 May 2024, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Ami Organics declined 7.54% to Rs 25.15 crore in the quarter ended March 2024 as against Rs 27.20 crore during the previous quarter ended March 2023. Sales rose 20.70% to Rs 224.96 crore in the quarter ended March 2024 as against Rs 186.38 crore during the previous quarter ended March 2023.For the full year,net profit declined 48.65% to Rs 42.77 crore in the year ended March 2024 as against Rs 83.29 crore during the previous year ended March 2023. Sales rose 16.33% to Rs 717.47 crore in the year ended March 2024 as against Rs 616.73 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales224.96186.38 21 717.47616.73 16 OPM %19.1921.92 -17.9119.88 - PBDT42.4340.09 6 130.04124.51 4 PBT37.5336.66 2 113.98112.17 2 NP25.1527.20 -8 42.7783.29 -49 Powered by Capital Market - Live News

AMI Organics will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

AMI Organics will hold a meeting of the Board of Directors of the Company on 26 April 2024.Powered by Capital Market - Live News